Cholesterol treatment in patients with acute coronary syndromes: does stating a target improve management?

Area of Science:

• Cardiology
• Lipid Metabolism
• Public Health

Background:

• High statin prescription rates exist for acute coronary syndromes (ACS) in New Zealand.
• The adoption of a treat to target approach for cholesterol management in ACS patients remains unclear.

Purpose of the Study:

• To evaluate the effectiveness of a 'treat to target' strategy in improving cholesterol management for ACS patients.
• To assess the impact of enhanced discharge documentation on achieving low-density lipoprotein-cholesterol (LDL-C) targets.

Main Methods:

• Retrospective and prospective examination of 200 ACS patients (100 per cohort).
• Intervention involved documenting LDL-C and target levels (<1.8 mmol/L) in discharge summaries with a follow-up lipid test prompt.
• Primary endpoint: achieving LDL-C <1.8 mmol/L within six months.

Main Results:

• In-hospital and outpatient lipid testing increased significantly post-intervention (98% vs 70% and 82% vs 60%, respectively).
• The primary outcome (LDL-C <1.8 mmol/L) was achieved more frequently in the intervention group (64% vs 47%).
• Follow-up LDL-C levels were significantly lower in the intervention group (1.73 ± 0.77 mmol/L vs 2.0 ± 1.1 mmol/L).

Conclusions:

• A treat to target approach was infrequently used at baseline.
• Documenting LDL-C targets in discharge summaries significantly improved lipid testing and goal attainment.
• The intervention demonstrated a positive impact on cholesterol management in ACS patients.